Alliance Pharma (LON:APH) Announces Quarterly Earnings Results

Alliance Pharma (LON:APH - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX 4.32 ($0.06) earnings per share for the quarter, Digital Look Earnings reports. Alliance Pharma had a negative return on equity of 15.24% and a negative net margin of 18.34%.

Alliance Pharma Price Performance

Shares of Alliance Pharma stock remained flat at GBX 64.20 ($0.84) during midday trading on Monday. The company had a trading volume of 123,494 shares, compared to its average volume of 5,905,285. Alliance Pharma has a one year low of GBX 24.55 ($0.32) and a one year high of GBX 66.20 ($0.87). The stock's fifty day moving average is GBX 62.94 and its two-hundred day moving average is GBX 53.56. The stock has a market capitalization of £347.61 million, a price-to-earnings ratio of -10.35, a PEG ratio of 1.04 and a beta of 0.67. The company has a current ratio of 2.93, a quick ratio of 1.42 and a debt-to-equity ratio of 46.27.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank cut shares of Alliance Pharma to a "hold" rating and dropped their target price for the company from GBX 7,000 ($91.59) to GBX 6,250 ($81.77) in a report on Wednesday, January 29th.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.